EKOS in Patients With Pulmonary Embolism (PE)
Launched by BENI-SUEF UNIVERSITY · Dec 13, 2024
Trial Information
Current as of June 20, 2025
Completed
Keywords
ClinConnect Summary
This clinical trial is studying the use of a treatment called EKOS in patients who have experienced a serious condition known as pulmonary embolism (PE), which occurs when blood clots block blood flow to the lungs. Specifically, the trial is looking at patients who did not respond well to initial blood-thinning medications. Eligible participants are adults aged 18 and older who are diagnosed with either massive or submassive acute PE, meaning they have significant blood flow blockage. However, those who are stable or have not received the EKOS treatment will not be included in the study.
If you or a loved one is eligible and chooses to participate, the main goal is to see how the EKOS treatment affects the size of the heart’s right and left chambers over time. Participants will have their heart measurements taken at the beginning of the study and again during a follow-up visit to see if there are any improvements. This trial is currently recruiting participants, and it aims to provide important information about the effectiveness of EKOS in treating serious cases of pulmonary embolism.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients ≥ 18 years diagnosed with massive or submassive acute PE.
- Exclusion Criteria:
- • 1. Patients presented with stable PE
- • 2. Patients did not receive EKOS intervention.
About Beni Suef University
Beni-Suef University is a prominent academic institution in Egypt dedicated to advancing medical research and clinical trials aimed at improving healthcare outcomes. With a strong emphasis on innovation and collaboration, the university fosters a multidisciplinary approach to research, engaging faculty, students, and healthcare professionals in the pursuit of scientific knowledge. The institution is committed to adhering to the highest ethical standards and regulatory guidelines, ensuring that all clinical trials conducted under its auspices are designed to enhance patient care and contribute to the global body of medical research. Through its initiatives, Beni-Suef University aims to translate research findings into practical applications that benefit communities locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported